Related Experiment Video
Updated: Mar 30, 2026
Differentiation of the SH-SY5Y Human Neuroblastoma Cell Line
Published on: February 17, 2016
Differentiation of human neuroblastoma cells toward the osteogenic lineage by mTOR inhibitor
A Carpentieri1, E Cozzoli1, M Scimeca2
1Biochemistry Laboratory, Department of Experimental Medicine and Surgery, University of Rome 'Tor Vergata', Rome 00133, Italy.
Abstract:
Current hypothesis suggest that tumors can originate from adult cells after a process of 'reprogramming' driven by genetic and epigenetic alterations. These cancer cells, called cancer stem cells (CSCs), are responsible for the tumor growth and metastases. To date, the research effort has been directed to the identification, isolation and manipulation of this cell population. Independently of whether tumors were triggered by a reprogramming of gene expression or seeded by stem cells, their energetic metabolism is altered compared with a normal cell, resulting in a high aerobic glycolytic 'Warburg' phenotype and dysregulation of mitochondrial activity. This metabolic alteration is intricately linked to cancer progression.The aim of this work has been to demonstrate the possibility of differentiating a neoplastic cell toward different germ layer lineages, by evaluating the morphological, metabolic and functional changes occurring in this process. The cellular differentiation reported in this study brings to different conclusions from those present in the current literature. We demonstrate that 'in vitro' neuroblastoma cancer cells (chosen as experimental model) are able to differentiate directly into osteoblastic (by rapamycin, an mTOR inhibitor) and hepatic lineage without an intermediate 'stem' cell step. This process seems owing to a synergy among few master molecules, metabolic changes and scaffold presence acting in a concerted way to control the cell fate.
Insights
Cancer cells can directly differentiate into multiple cell types without an intermediate stem cell stage. This study shows neuroblastoma cells can become osteoblastic and hepatic cells, challenging current cancer stem cell hypotheses.
Area of Science:
- Oncology
- Cell Biology
- Metabolic Research
Background:
- Tumors are hypothesized to arise from reprogrammed adult cells, forming cancer stem cells (CSCs) driving tumor growth and metastasis.
- CSCs exhibit altered metabolism, including the Warburg effect and mitochondrial dysfunction, linked to cancer progression.
- Current research focuses on identifying, isolating, and manipulating CSCs.
Purpose of the Study:
- To investigate the direct differentiation potential of neoplastic cells into different germ layer lineages.
- To evaluate morphological, metabolic, and functional changes during neoplastic cell differentiation.
- To challenge existing models of tumor origin and cancer stem cell involvement.
Main Methods:
- Utilized in vitro neuroblastoma cancer cells as an experimental model.
- Administered rapamycin, an mTOR inhibitor, to induce differentiation.
- Assessed differentiation through morphological, metabolic, and functional analyses.
Main Results:
- Demonstrated direct differentiation of neuroblastoma cells into osteoblastic and hepatic lineages.
- Showed this differentiation occurs without an intermediate cancer stem cell step.
- Identified a synergy between master molecules, metabolic shifts, and scaffold presence in controlling cell fate.
Conclusions:
- Neoplastic cells can directly differentiate into multiple lineages, bypassing a stem cell intermediate.
- This finding offers a new perspective on tumor development and cancer cell plasticity.
- Metabolic alterations and specific molecular cues play a crucial role in directing cell fate.
